Discovery Acceleration
InMatch is MotionHall’s novel In-licensing and Buy-side M&A discovery tool. Expansive AI Search & Evaluation combs the global landscape to surface a body of clinical and preclinical candidates that fit your company and pipeline strategy.
Why InMatch?
InMatch drastically reduces the amount of data labour required to win and execute successful in-licensing discovery projects. Companies that use InMatch benefit from accelerated asset search & evaluation.

Who Uses InMatch?
• Biotechs looking to scour the global landscape of pre-clinical and clinical candidates for in-licensing

• Strategic Consultancies and Investment Banks dedicated to the Life Sciences

• Companies that do not wish to miss out on interesting asset candidates being developed around the world

• Companies that care about global comprehensiveness for asset search & evaluation

Get in touch with our team for a free consultation.

An extraordinary approach to effective partnering.

Ready to get started?